High-density lipoprotein and progression rate of atherosclerosis in intravascular ultrasound trials.
DOI: 10.1016/J.AMJCARD.2009.09.015
关键词: Internal medicine 、 Intravascular ultrasound 、 Atherosclerosis imaging 、 Clinical trial 、 Cardiology 、 Lipoprotein 、 Progression rate 、 Cholesterol 、 High-density lipoprotein 、 Arterial wall 、 Medicine
摘要: Increasing interest has focused on the potential clinical utility of therapies that promote biologic activity high-density lipoprotein (HDL). Arterial wall imaging been used in trials to demonstrate elevating HDL cholesterol a beneficial impact natural history progression atherosclerosis. As result, it is likely atherosclerosis will become an integral component early development novel enhance functionality HDL.
elsevier.com
sci-hub.se 参考文章(66)
E.M Tuzcu, A Askari, S J Nicholls, A Perez, T Hu, V S Srinivas, R W Nesto, O Bayturan, Menon, S Kupfer, S E Nissen, Abstract 5052: Lowering of the Triglyceride/HDL Cholesterol Ratio Predicts the Benefit of Pioglitazone on Progression of Coronary Atherosclerosis in Diabetic Patients Circulation. ,vol. 118, ,(2008)
Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels The New England Journal of Medicine. ,vol. 339, pp. 1349- 1357 ,(1998) , 10.1056/NEJM199811053391902
Salim Yusuf, MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20536 high-risk individuals: a randomised placebo-controlled trial. Commentary The Lancet. ,vol. 360, pp. 7- 22 ,(2002)
Effect of fenofibrate on progression of coronary-artery disease in type 2 diabetes: the Diabetes Atherosclerosis Intervention Study, a randomised study The Lancet. ,vol. 357, pp. 905- 910 ,(2001) , 10.1016/S0140-6736(00)04209-4
Vasilios G. Athyros, Dimitri P. Mikhailidis, Athanasios A. Papageorgiou, Athanasios N. Symeonidis, Bodosakis R. Mercouris, Anthimos N. Pehlivanidis, Vasilios I. Bouloukos, Moses Elisaf, , Effect of atorvastatin on high density lipoprotein cholesterol and its relationship with coronary events: a subgroup analysis of the GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) Study. Current Medical Research and Opinion. ,vol. 20, pp. 627- 637 ,(2004) , 10.1185/030079904125003421
Steven E Nissen, Jean-Claude Tardif, Stephen J Nicholls, James H Revkin, Charles L Shear, William T Duggan, Witold Ruzyllo, William B Bachinsky, Gabriel P Lasala, E Murat Tuzcu, None, Effect of Torcetrapib on the Progression of Coronary Atherosclerosis The New England Journal of Medicine. ,vol. 356, pp. 1304- 1316 ,(2007) , 10.1056/NEJMOA070635
Allen J. Taylor, Hyun J. Lee, Lance E. Sullenberger, The effect of 24 months of combination statin and extended-release niacin on carotid intima-media thickness: ARBITER 3. Current Medical Research and Opinion. ,vol. 22, pp. 2243- 2250 ,(2006) , 10.1185/030079906X148508
A. Michael Lincoff, Kathy Wolski, Stephen J. Nicholls, Steven E. Nissen, Pioglitazone and Risk of Cardiovascular Events in Patients With Type 2 Diabetes Mellitus JAMA. ,vol. 298, pp. 1180- 1188 ,(2007) , 10.1001/JAMA.298.10.1180
Steven E. Nissen, Stephen J. Nicholls, Kathy Wolski, Richard Nesto, Stuart Kupfer, Alfonso Perez, Horacio Jure, Robert De Larochellière, Cezar S. Staniloae, Kreton Mavromatis, Jacqueline Saw, Bo Hu, A. Michael Lincoff, E. Murat Tuzcu, for the PERISCOPE Investigators, Comparison of Pioglitazone vs Glimepiride on Progression of Coronary Atherosclerosis in Patients With Type 2 Diabetes: The PERISCOPE Randomized Controlled Trial JAMA. ,vol. 299, pp. 1561- 1573 ,(2008) , 10.1001/JAMA.299.13.1561
Hiroshi Okamoto, Fumihiko Yonemori, Korekiyo Wakitani, Takashi Minowa, Kimiya Maeda, Hisashi Shinkai, A cholesteryl ester transfer protein inhibitor attenuates atherosclerosis in rabbits Nature. ,vol. 406, pp. 203- 207 ,(2000) , 10.1038/35018119